Attached files
| file | filename |
|---|---|
| 10-Q - QUARTERLY REPORT - LifeMD, Inc. | f10q0917_immudyneinc.htm |
| EX-31.2 - CERTIFICATION - LifeMD, Inc. | f10q0917ex31-2_immudyne.htm |
| EX-31.1 - CERTIFICATION - LifeMD, Inc. | f10q0917ex31-1_immudyne.htm |
Exhibit 32.1
CERTIFICATIONS OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER
PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
I, Mark McLaughlin, certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report on Form 10-Q of Immudyne, Inc. for the quarterly period ended September 30, 2017, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Quarterly Report on Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of Immudyne, Inc.
| Date: November 14, 2017 | By: | /s/ Mark McLaughlin |
Mark McLaughlin Chief Executive Officer |
I, Robert Kalkstein, certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report on Form 10-Q of Immudyne, Inc. for the quarterly period ended September 30, 2017, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Quarterly Report on Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of Immudyne, Inc.
| Date: November 14, 2017 | By: | /s/ Robert Kalkstein |
Robert Kalkstein Chief Financial Officer |
The foregoing certifications are not deemed filed with the Securities and Exchange Commission for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or the Exchange Act, and are not to be incorporated by reference into any filing of Immudyne, Inc. under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, regardless of any general incorporation language in such filing.